Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc > does anyone see this stock hitting $8.00 in the future?

<< Previous

Bullboard Posts

Next >>

Comment by FriedChickenon Feb 02, 2021 10:01pm

216 Views

Post# 32455005

RE:RE:RE:does anyone see this stock hitting $8.00 in the future?

You invested in a different company back then. Not sure that we will see $8 this year, but possible next. Think of averaging down a bit, at $0.50 it should be easy to get you average cost down considerably.

i can see us at 3 or 4 bucks this year. Probably $2 within the next 2-3 months.

cheers
FC

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity